Welcome to LookChem.com Sign In|Join Free

CAS

  • or

848357-95-9

Post Buying Request

848357-95-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2-borono-5-methoxy-1H-Pyrrolo[3,2-b]pyridine-1-carboxylic acid 1-(1,1-dimethylethyl)ester

    Cas No: 848357-95-9

  • No Data

  • No Data

  • No Data

  • Debye Scientific
  • Contact Supplier

848357-95-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 848357-95-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,3,5 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 848357-95:
(8*8)+(7*4)+(6*8)+(5*3)+(4*5)+(3*7)+(2*9)+(1*5)=219
219 % 10 = 9
So 848357-95-9 is a valid CAS Registry Number.

848357-95-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name (1-(tert-butoxycarbonyl)-5-methoxy-1H-pyrrolo[3,2-b]pyridin-2-yl)boronic acid

1.2 Other means of identification

Product number -
Other names 5-methoxypyrrolo[3,2-b]pyridine-2-boronic acid 1-carboxylic acid tert-butyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:848357-95-9 SDS

848357-95-9Relevant articles and documents

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

-

, (2014/08/07)

The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

Novel organophosphorus derivatives of indazoles and use thereof as medicinal products

-

Page/Page column 32, (2008/06/13)

The present invention relates in particular to novel chemical compounds, particularly to novel organophosphorus derivatives of indazoles, to the compositions containing them, and to the use thereof as medicinal products for treating cancers.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 848357-95-9